Recurrent or Metastatic Solid Tumors Clinical Trial
Official title:
An Exploratory Study of A-337 in the Management of Malignant Solid Dose
Title: An Exploratory Study of A-337 in the Management of Malignant Solid Dose Escalation and Expansion Phases
Protocol Number: IM-2021A Study Stage: Phase I Study Number: 2-3 sites Subject Number: up to 94 patients with recurrent or metastatic solid tumors, for whom there are no available effective standard treatments or for whom standard treatments have proven ineffective or intolerable. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02221960 -
A Phase 1 Study to Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06330064 -
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXD) In Subjects With Recurrent Or Metastatic Solid Tumors
|
Phase 2 |